1. Park KH, Jeong MH, Kim HK, Ki YJ, Kim SS, Ahn Y, Kook HY, Kim HS, Gwon HC, Seung KB, Rha SW, Chae SC, Kim CJ, Cha KS, Park JS, Yoon JH, Chae JK, Joo SJ, Choi DJ, Hur SH, Seong IW, Cho MC, Kim DI, Oh SK, Ahn TH, Hwang JY; KAMIR-NIH registry investigators. The current status and outcomes of in-hospital P2Y12 receptor inhibitor switching in Korean patients with acute myocardial infarction. Korean J Intern Med. 2022 Mar;37(2):350-365.
2. Park KH, Jeong MH, Kim HK, Ki YJ, Kim SS, Choi DH, Koh YY, Ahn Y, Kim HS, Gwon HC, Rha SW, Hwang JY; KAMIR-NIH registry investigators. Clinical Outcomes of Ticagrelor in Korean Patients with Acute Myocardial Infarction without High Bleeding Risk. J Korean Med Sci. 2021 Nov 1;36(42):e268.
3. Park KH, Kim DH, Jang SW, Ryu JH, Ko KY. Treatment of Recurrent Hemarthrosis Following Total Knee Arthroplasty Using Surgical Interventions. Clin Orthop Surg. 2021 Jun;13(2):152-159.
4. Park KH, Ahn Y, Koh YY, Ki YJ, Kim SS, Kim HK, Choi DH, Hong YJ, Hwang JY, Kim DH, Rhew JY, Ryu JK, Park JS, Park TH, Yang TH, Oh SK, Lee BR, Lee SU, Lee SG, Chun KJ, Cho JH, Cha KS, Chae JK, Hur SH, Hwang SH, Park HS, Kim DI. Effectiveness and Safety of Zotarolimus-Eluting Stent (Resolute™ Integrity) in Patients with Diffuse Long Coronary Artery Disease. Korean Circ J. 2019 Aug;49(8):709-720.
5. Park KH, Jeong MH, Kim HK, Ahn TH, Seung KB, Oh DJ, Choi DJ, Kim HS, Gwon HC, Seong IW, Hwang KK, Chae SC, Kim KB, Kim YJ, Cha KS, Oh SK, Chae JK. Comparison of prasugrel versus clopidogrel in Korean patients with acute myocardial infarction undergoing successful revascularization. J Cardiol 2018;71(1):36-43.
6. Park KH, Jeong MH, Hong YJ, Ahn Y, Kim HK, Koh YY, Kim DI, Kim SW, Kim W, Rha SW, Rhew JY, Park JS, Park HS, Bae JH, Bae JW, Oh SK, Lee SY, Lee SW, Lee JH, Lim SY, Cho JH, Cha KS, Chae JK, Hur SH, Hwang SH, Hwang JY. Effectiveness and Safety of Biolimus A9™-Eluting stEnt in Patients with AcUTe Coronary sYndrome; A Multicenter, Observational Study (BEAUTY Study). Yonsei Med J. 2018 Jan;59(1):72-79.
7. Park KH, Jeong MH, Ahn Y, Ahn TH, Seung KB, Oh DJ, Choi DJ, Kim HS, Gwon HC, Seong IW, Hwang KK, Chae SC, Kim KB, Kim YJ, Cha KS, Oh SK, Chae JK; KAMIR-NIH registry investigators. Comparison of short-term clinical outcomes between ticagrelor versus clopidogrel in patients with acute myocardial infarction undergoing successful revascularization; from Korea Acute Myocardial Infarction Registry-National Institute of Health. Int J Cardiol. 2016 Jul 15;215:193-200.
8. Kang SH, Park KH, Ahn HS, Park KW, Hong YJ, Koo BK, Jeong MH, Kim HS. Everolimus-eluting versus sirolimus-eluting coronary stents in patients with and without diabetes mellitus. EuroIntervention. 2014 May 20;10(1):74-82.
9. Park KH, Jeong MH, Ahn Y, Jung SS, Kim MH, Yang HM, Yoon J, Rha SW, Park KS, Han KR, Cho BR, Cha KS, Kim BO, Hyon MS, Shin WY, Choe H, Bae JW, Kim HY; Trans-Radial Intervention Registry Investigators. The impact of vascular access for in-hospital major bleeding in patients with acute coronary syndrome at moderate- to very high-bleeding risk. J Korean Med Sci. 2013 Sep;28(9):1307-15.
10. Park KH, Jeong MH, Lee KH, Sim DS, Yoon HJ, Yoon NS, Kim KH, Park HW, Hong YJ, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC. Comparison of peri-procedural platelet inhibition with prasugrel versus adjunctive cilostazol to dual anti-platelet therapy in patients with ST segment elevation myocardial infarction. J Cardiol. 2014 Feb;63(2):99-105.
11. Park KH, Jeong MH, Kim JM, Park DS, Kim JH, Lim KS, Lee KH, Sim DS, Yoon HJ, Yoon NS, Kim KH, Park HW, Hong YJ, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC. The impact of triple anti-platelet therapy for endothelialization and inflammatory response at overlapping bioabsorbable polymer coated drug-eluting stents in a porcine coronary model. Int J Cardiol. 2013 Oct 3;168(3):1853-8.
12. Park KH, Ahn Y, Jeong MH, Chae SC, Hur SH, Kim YJ, Seong IW, Chae JK, Hong TJ, Cho MC, Bae JH, Rha SW, Jang YS; Korean Acute Myocardial Infarction Registry Investigators. Different impact of diabetes mellitus on in-hospital and 1-year mortality in patients with acute myocardial infarction who underwent successful percutaneous coronary intervention: results from the Korean Acute Myocardial Infarction Registry. Korean J Intern Med. 2012 Jun;27(2):180-8.
13. Park KH, Jeong MH, Lee MG, Ko JS, Sim DS, Yoon NS, Yoon HJ, Hong YJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC. What is the optimal duration of triple anti-platelet therapy in patients with acute myocardial infarction undergoing drug-eluting stent implantation? J Cardiol. 2011 Jan;57(1):53-60.
14. Park KH, Jeong MH, Lee MG, Ko JS, Lee SE, Kang WY, Kim SH, Sim DS, Yoon NS, Youn HJ, Hong YJ, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC. Efficacy of triple anti-platelet therapy including cilostazol in acute myocardial infarction patients undergoing drug-eluting stent implantation. Korean Circ J. 2009 May;39(5):190-7.
